Fifth Third Wealth Advisors LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1899030 Cincinnati, OH

Position in REGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$1,351,834

-$556,586 QoQ

Shares Held

2,168

-12.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#592

of 1,322 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fifth Third Wealth Advisors LLC holds $7,687,403 across 13 Biotechnology names. REGN ranks #2 (17.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	18,943	$2,147,378
2	REGN	Regeneron Pharmaceuticals, Inc. This page	2,168	$1,351,834
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,849	$918,453
4	EXEL	Exelixis, Inc.	9,050	$492,410
5	JAZZ	Jazz Pharmaceuticals plc	1,994	$480,494
6	CYTK	Cytokinetics Inc	5,154	$439,069
7	KRYS	Krystal Biotech, Inc.	1,109	$412,182
8	ROIV	Roivant Sciences Ltd.	10,744	$380,230

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,351,834	2,168	-12.2%	Shares	Sole	2026-07-17
2026-03-31	$1,908,420	2,470	+49.7%	Shares	Sole	2026-04-20
2025-12-31	$1,273,585	1,650	+5.7%	Shares	Sole	2026-01-15
2025-09-30	$877,703	1,561	+3.3%	Shares	Sole	2025-10-21
2025-06-30	$793,275	1,511	+11.3%	Shares	Sole	2025-07-25
2025-03-31	$860,650	1,357	+23.5%	Shares	Sole	2025-04-08
2024-12-31	$782,850	1,099	+118.1%	Shares	Sole	2025-01-14
2024-09-30	$529,824	504	+27.0%	Shares	Sole	2024-11-07
2024-06-30	$417,258	397	+76.4%	Shares	Sole	2024-07-23
2024-03-31	$216,560	225	—	Shares	Sole	2024-04-16
No filing history on record for this holder in this stock.